These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6275252)

  • 1. Complement-fixing antibodies to human cytomegalovirus induced early nuclear antigens in mononucleosis.
    Gergely L; Gzeglédy J; Váczi L
    Med Microbiol Immunol; 1981; 170(2):99-108. PubMed ID: 6275252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-human cytomegalovirus nuclear antigen antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Vályi-Nagy T
    Acta Virol; 1982 Jan; 26(1-2):73-8. PubMed ID: 6124112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.
    Lang D; Vornhagen R; Rothe M; Hinderer W; Sonneborn HH; Plachter B
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):747-56. PubMed ID: 11427421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus and cytomegalovirus antibodies in infectious mononucleosis.
    Gergely L; Czeglédy J; Szalka A; Váczi L; Binder L
    Acta Microbiol Acad Sci Hung; 1977; 24(1):13-9. PubMed ID: 201153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive method to detect non-complement-fixing antibodies to Epstein-Barr virus nuclear antigne.
    Schmitz H; Kampa D; Heidenreich W
    Int J Cancer; 1975 Dec; 16(6):1030-4. PubMed ID: 172458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection.
    Alberola J; Tamarit A; Igual R; Navarro D
    J Clin Virol; 2000 Apr; 16(2):113-22. PubMed ID: 10720815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Szalka A
    Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution to rapid diagnosis of infectious mononucleosis.
    Franková V; Stanková M; Kouba K; Hásková V; Pavlík E
    Acta Virol; 1986 May; 30(3):234-42. PubMed ID: 2874728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the presence of antibodies to EB virus and other herpesviruses in normal children and in infectious mononucleosis.
    Gergely L; Czeglédy J; Váczi L; Szabó B; Binder L; Szalka A
    Acta Microbiol Acad Sci Hung; 1975; 22(2):75-82. PubMed ID: 164758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM antibodies to Epstein-Barr virus-associated membrane antigen in sera of infectious mononucleosis patients.
    Harada M; Sairenji T; Takaki K; Hinuma Y
    Microbiol Immunol; 1980; 24(2):123-32. PubMed ID: 6247623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
    Fark AR
    J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis.
    Sculley TB; Pope JH; Hazelton RA
    Arthritis Rheum; 1986 Aug; 29(8):964-70. PubMed ID: 3017369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCR detection of viral DNA in serum as an ancillary analysis for the diagnosis of acute mononucleosis-like syndrome due to human cytomegalovirus (HCMV) in immunocompetent patients.
    Navalpotro D; Gimeno C; Navarro D
    J Clin Virol; 2006 Feb; 35(2):193-6. PubMed ID: 16125456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of serological criteria for the diagnosis of infectious mononucleosis].
    de Ory F; Echevarría JM
    Enferm Infecc Microbiol Clin; 1989 Nov; 7(9):485-8. PubMed ID: 2562304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte reactivity in infectious mononucleosis.
    ten Napel CH; The TH
    J Infect Dis; 1980 Jun; 141(6):716-23. PubMed ID: 6248602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infectious mononucleosis. Determination of immunofluorescent antibodies against the Epstein-Barr virus and complement-fixation antibodies against the cytomegalovirus].
    Lasovská J; Kouba K; Sobĕslavský O; Seeman J; Moravcová E; Kucharská Z; Vojtĕchovský K
    Cas Lek Cesk; 1973 Jan; 112(2):38-42. PubMed ID: 4345614
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytomegalovirus in the mononucleosis syndrome in children.
    Najberg G; Jankowski M; Krotochwil-Skrzypkowa M; Gut W
    Acta Microbiol Pol; 1985; 34(2):137-44. PubMed ID: 2412401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serodiagnosis of infectious mononucleosis in children.
    Wakiguchi H; Hisakawa H; Kubota H; Kurashige T
    Acta Paediatr Jpn; 1998 Aug; 40(4):328-32. PubMed ID: 9745774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-dependent, Epstein-Barr virus-neutralizing antibody appearing early in the sera of patients with infectious mononucleosis.
    Sairenji T; Sullivan JL; Humphreys RE
    J Infect Dis; 1984 May; 149(5):763-8. PubMed ID: 6327851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.